Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
Vibrio Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Culture Media, Polymerase Chain reaction, PCR Kits, Immunoassays, Others), By End-user (Hospitals, Diagnostic Laboratories, Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Vibrio Diagnostics market size is poised to register 6.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vibrio Diagnostics market across ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Immunoassay for Neurological Biomarkers market size is poised to register 17.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
In-Vitro Toxicology Testing Market Size, Trends, Analysis, and Outlook By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging Technology, OMICS Technology), By Product (Consumables, Assays, Instruments, Software, Services), By Method (Cellular Assay (Live Cells (High Throughput / High Content Screening, Molecular Imaging (Confocal Microscopy, Others), Others), Fixed Cells), Biochemical Assay, In Silico, Ex-vivo)), By Application (Systemic Toxicology (Acute Toxicity, Carcinogenicity, Developmental Toxicity, Others), Dermal Toxicity (Skin Irritation Test, Skin Sensitization Test, Skin Corrosion Test, Phototoxicity Test, Others), Endocrine Disruption (Dioxins, Phthalates, Polychlorinated biphenyls (PCB)), Ocular Toxicity (Intravitreal, Subretinal, Others), Others (Immunotoxicity, Reproductive Toxicity, Neurotoxicity, Epigenetic Alterations, Genotoxicity, Others), By End-user (Pharmaceutical Industry, Cosmetics & Household Products, Academic Institutes & Rese
... (High Throughput / High Content Screening, Molecular Imaging (Confocal Microscopy, Others), Others), Fixed Cells), Biochemical Assay, In Silico, Ex-vivo)), By Application (Systemic Toxicology (Acute Toxicity, Carcinogenicity, Developmental Toxicity, Others), Dermal Toxicity (Skin Irritation Test, Skin ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Trends, Analysis, and Outlook By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ... Read More
-
In vitro Diagnostics Enzymes Market Size, Trends, Analysis, and Outlook By Type (Proteases, Polymerase & Transcriptase, Ribonuclease, Others), By Disease , Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Others), By Technology (Histology Assays, Molecular Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, by Region, Country, Segment, and Companies, 2024-2030
... Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, by Region, Country, Segment, and Companies, 2024-2030 The global In vitro Diagnostics ... Read More
-
Healthcare Specialty Enzymes Market Size, Trends, Analysis, and Outlook By Product (Carbohydrases, Polymerases and Nucleases, Proteases, Lipases, Phosphatases/Phytases, Others), By Source (Micro-organisms, Animals, Plants), By Technique (Clinical Chemistry, Immunodiagnostics/Immunoassays, Molecular Diagnostics, Hematology, Microbiology), By Usage (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Healthcare Specialty Enzymes market size is poised ... Read More
-
Enteric Disease Testing Market Size, Trends, Analysis, and Outlook By Product (Reagents and Consumables, Equipment), By Technique (Molecular Diagnostics, Immunodiagnostics), By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease), By End-User (Academic and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 The global Enteric Disease Testing market size is poised to register 3.94% growth from 2024 to 2030, presenting significant ... Read More
-
Immunoprotein Diagnostic Testing Market Size, Trends, Analysis, and Outlook By Test (Complement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests, C-Reactive Protein (CRP) Diagnostic Tests), By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, ... Read More
-
The 2025-2030 World Outlook for Estradiol (E2) Endocrine Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Liquid Handling Systems
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Serine Protease Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Immunoassays
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Immuno Oncology Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Immunoassay Reagents and Devices
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Syphilis Immunoassays
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immunoassay Reagents
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immunoassay and Immunochemistry in Vitro Diagnostics
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Immunoassay Interference Blockers
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Research ELISA (Enzyme-Linked Immunosorbent Assay)
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Immunofluorescence Assays
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biotechnology Immunoassay Instrumentation Systems
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Dye-Binding Protein Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for miRNA Sequencing and Assays
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Creatinine Assay Kits
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cell-Based Assay Consumables
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
